NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i |
|
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: |
Advanced Medical Solutions Group plc |
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) |
Non-UK issuer |
|
2. Reason for the notification (please mark the appropriate box or boxes with an "X") |
An acquisition or disposal of voting rights |
X |
An acquisition or disposal of financial instruments |
X |
An event changing the breakdown of voting rights |
|
Other (please specify)iii: |
|
3. Details of person subject to the notification obligationiv |
Name |
Aviva plc & its subsidiaries |
City and country of registered office (if applicable) |
London, England |
4. Full name of shareholder(s) (if different from 3.)v |
Name |
Registered Holder: Available on request 6,009* Chase (GA Group) Nominees Limited 8,245,260* Chase Nominees Limited 162,670* *denotes direct interest |
City and country of registered office (if applicable) |
|
5. Date on which the threshold was crossed or reachedvi: |
30/10/2017 |
6. Date on which issuer notified (DD/MM/YYYY): |
31/10/2017 |
7. Total positions of person(s) subject to the notification obligation |
|
% of voting rights attached to shares (total of 8. A) |
% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) |
Total number of voting rights of issuervii |
Resulting situation on the date on which threshold was crossed or reached |
3.967% |
0.158% |
4.125% |
212,118,648 |
Position of previous notification (if applicable) |
4.08% |
0.02% |
4.10% |
|
|
|
|
|
|
|
|
|
